ETMarkets.com
Synopsis
Pharma as a sector has been under pressure for a very long time. However, some of the small and mid sized Indian pharma companies which are not hit by pricing pressure of the US generic market and other issues which large pharma companies have been facing keep attracting interest from the analyst. The list is based on upside estimated by the analysts, with the highest potential stock coming on the top of the list.
By ETMarkets.com
6 mins read, Last Updated:
Pharma as a sector has been witnessing a mixed newflow. Select domestic pharma companies which have been pushing for backward integration have seen some improvement in their margins. At the same time some headwinds have again resurfaced for large pharma companies whose fortunes are tied up with pricing trends in US markets. Pricing pressure in generic drugs is back on the table for these large pharma companies. Though in last few months, the
Membership Benefits
Access the exclusive Economic Times
Stories, Editorial & Expert opinion
Complete Access with ET Prime
Experience your Economic Times newspaper, the digital way.
Clean experience
with minimal ads
Easy & distraction-free reading with 90% less ads
Sharp Insight-rich,
In-depth stories across 20+ sectors
1500+ Exclusive stories & analysis across sectors to help you stay informed
Get One Year Times Prime Subscription worth ₹1199 for free
Get One Year Docubay Subscription worth ₹999 for free
Stream award-winning international documentaries from more than 100 countries.
Member only Newsletters
Never miss a story that matters
Members Love Us
The stalwarts of the industry trust ET Prime for insightful analysis & unbiased thought pieces
Gift a story
Your membership includes Story Gifting Credits. Now gift exclusive stories to your friends & peers.
Comment & Engage
with ET Prime community
Communicate & build a connection with great minds of the industry
A trusted team of
Journalists & Analysts
Unbiased perspective & detailed reporting by our team of journalists who have in-depth knowledge and years of experience
 "India reiterates opposition to China’s Belt and Road Initiative at SCO meet | External Affairs Defence Security News")
 "Trade deficit eases to $20.8 bn in Sept amid geopolitical challenges | Economy & Policy News")
 "HK-based Executive Centre to invest Rs 125 cr to grow India business | Company News")
